The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Acerta Pharma; Celgene; Genentech; Gilead Sciences; Nordic Nanovector; Novartis; Pfizer
Consulting or Advisory Role - Acerta Pharma; Celgene; Genentech; Gilead Sciences; Nordic Nanovector; Novartis; Pfizer
Research Funding - Acerta Pharma; Celgene; Genentech; Gilead Sciences; Novartis
 
Research Funding - Celltrion; Eisai; Johnson & Johnson; Kyowa Hakko Kirin; Mundipharma; Pfizer; Roche; Takeda
Managing cytokine release syndrome (CRS) and neurotoxicity with step-fractionated dosing of mosunetuzumab in relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL).
 
Nancy L. Bartlett
Consulting or Advisory Role - ADC Therapeutics; Pfizer; Seagen
Research Funding - Affimed Therapeutics (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Forty Seven (Inst); Genentech (Inst); Gilead Sciences (Inst); Immune Design (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Merck (Inst); Millennium (Inst); Pharmacyclics (Inst); Seagen (Inst)
 
Laurie Helen Sehn
Honoraria - Abbvie; Acerta Pharma; Amgen; Apobiologix; AstraZeneca; Celgene; Gilead Sciences; Janssen-Ortho; Karyopharm Therapeutics; Kite, a Gilead company; Lundbeck; Merck; morphosys; Roche/Genentech; Seagen; Seagen; Takeda; Takeda; Teva; TG Therapeutics
Consulting or Advisory Role - Abbvie; Acerta Pharma; Amgen; Amgen; apobiologix; AstraZeneca; Celgene; Gilead Sciences; Janssen; Karyopharm Therapeutics; Kite, a Gilead company; Lundbeck; Merck; MorphoSys; Roche/Genentech; Seagen; Takeda; Teva; TG Therapeutics; TG therapeutics
Research Funding - Roche/Genentech (Inst)
 
Sarit E. Assouline
Stock and Other Ownership Interests - Knight Pharmaceuticals
Honoraria - Janssen Oncology; Pfizer
Consulting or Advisory Role - Abbvie; Roche Canada
Speakers' Bureau - Bristol-Myers Squibb; Janssen; Pfizer
Research Funding - Astex Pharmaceuticals (Inst); BeiGene (Inst); epizyme (Inst); Gilead Sciences (Inst); Janssen (Inst); Novartis (Inst); Roche Canada (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Roche Canada
 
Francesc Bosch
Honoraria - Abbvie; Celgene; Gilead Sciences; Janssen; Novartis; Roche
Consulting or Advisory Role - Abbvie; Celgene; Gilead Sciences; Janssen; Novartis; Roche
Speakers' Bureau - Abbvie; Celgene; Gilead Sciences; Janssen; Novartis; Roche
Research Funding - Abbvie; Bayer; Celgene; Gilead Sciences; Janssen; Novartis; Roche; SOBI
 
Catherine S. Magid Diefenbach
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genentech/Roche; Janssen; Merck; Seagen
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); Incyte (Inst); Janssen (Inst); LAM Therapeutics (Inst); MEI Pharma (Inst); Merck (Inst); Millennium (Inst); Roche/Genentech (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Roche (Inst)
 
Ian Flinn
Consulting or Advisory Role - Abbvie (Inst); Seagen (Inst); TG Therapeutics (Inst); Verastem (Inst)
Research Funding - Abbvie (Inst); Abbvie (Inst); Acerta Pharma (Inst); Agios (Inst); ArQule (Inst); AstraZeneca (Inst); BeiGene (Inst); Calithera Biosciences (Inst); Celgene (Inst); Constellation Pharmaceuticals (Inst); Curis (Inst); FORMA Therapeutics (Inst); Forty Seven (Inst); Genentech (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Incyte (Inst); Infinity Pharmaceuticals (Inst); Janssen (Inst); Juno Therapeutics (Inst); Karyopharm Therapeutics (Inst); Kite, a Gilead company (Inst); Merck (Inst); MorphoSys (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Portola Pharmaceuticals (Inst); Roche (Inst); Takeda (Inst); Teva (Inst); TG Therapeutics (Inst); Trillium Therapeutics (Inst); Unum Therapeutics (Inst); Verastem (Inst)
 
Jungyong Hong
Honoraria - Celgene; Celltrion; Eisai; Janssen; Mundipharma; Roche; Takeda
Consulting or Advisory Role - Roche; Takeda
Research Funding - Boryung; Janssen
 
Wonseog S Kim
No Relationships to Disclose
 
Matthew J. Matasar
Stock and Other Ownership Interests - Merck
Honoraria - Bayer; Genentech; GlaxoSmithKline; Janssen; Pharmacyclics; Roche; Seagen
Consulting or Advisory Role - Bayer; Genentech; Juno Therapeutics; Merck; Roche; Rocket Medical; Seagen; Teva
Research Funding - Bayer; Genentech; GlaxoSmithKline; Janssen; Pharmacyclics; Roche; Rocket Medical; Seagen
Travel, Accommodations, Expenses - Bayer; Genentech; Roche; Seagen
 
Loretta J. Nastoupil
Honoraria - Bayer; Celgene; Gilead Sciences; Janssen Oncology; Novartis; Spectrum Pharmaceuticals
Research Funding - Celgene; Genentech/Roche; Janssen Biotech; Karus Therapeutics; LAM Therapeutics; TG Therapeutics
 
Stephen J Schuster
No Relationships to Disclose
 
Mazyar Shadman
Consulting or Advisory Role - Abbvie; ADC Therapeutics; AstraZeneca; Atara Biotherapeutics; Genentech; Sound Biologics; Verastem
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); BeiGene (Inst); Celgene (Inst); Emergent BioSolutions (Inst); Genentech (Inst); Gilead Sciences (Inst); Merck (Inst); MustangBio (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
 
Sung-Soo Yoon
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Novartis; Roche
Research Funding - Roche
 
Brendan Bender
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Antonia Kwan
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
Wang Cunlin
Employment - Ultragenyx Pharmaceuticals
 
Michael C. Wei
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Shen Yin
Employment - Genentech
Stock and Other Ownership Interests - Genentech
Travel, Accommodations, Expenses - Genentech
 
Kasra Yousefi
Employment - Roche
Travel, Accommodations, Expenses - Roche
 
L. Elizabeth Budde
Consulting or Advisory Role - AstraZeneca; Genentech; Gilead Sciences
Speakers' Bureau - AstraZeneca; Gilead Sciences
Research Funding - Amgen; Merck; MustangBio